Emma Goodhead

Emma joined Gentronix in 2016 and is currently a Study Director for bacterial reverse mutation (Ames Test) assays. She is an experienced genetic toxicologist having worked for >25 years in GLP-compliant laboratories carrying out genetic toxicology assays including cytogenetic assays, the bacterial reverse mutation assay (Ames test), mammalian gene mutation and Comet assay endpoints.